Globus Medical (GMED) Stock Price, Quote, News & History | Benzinga

Globus Medical Inc (GMED) Stock Price, Quote, News & History

GMEDNYSE

Trade with Public

Trade with Public

$78.53

-2.13-2.64%

Last update: Sep 3, 3:30 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$80.43

Close

-

Volume / Avg.

897.86K / 1.60M

Day Range

$78.22 - $81.14

52 Wk Range

54.15 - 101.40

Market Cap

$10.54B

P/E Ratio

20.63

Dividend Yield

-

Exchange

NYSE

RSI

37

Short Interest

6.13%

Days to Cover

3.95

Recent Globus Medical, Inc. News

AI Chips Power Wall Street Higher, Dow Eyes Records: Stock Market Today

Tech and semis lead the S&P 500 and Nasdaq higher into quarter-end

Piero Cingari

Paychex To Rally More Than 39%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on top names. See all rating changes on our analyst ratings page. Barclays, Wells Fargo, Piper Sandler, Leerink Partners, Truist Securities, and Citigroup updated their price targets and ratings for AVA, LEN, GMED, SABS, PDM, and PAYX. Evercore ISI Group and Truist Securities also raised their price targets and ratings for LEN and DDOG.

Avi Kapoor

Jim Cramer Flags Industrial Company With 'Almost No Revenue,' Says No To Rocket Companies

Cramer says Rocket Companies is a "play" on the idea that new Fed Chair Kevin Warsh will cut interest rates, and that's a long shot.

Avi Kapoor

This Southwest Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday

Avi Kapoor

Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio?

Expedia, SanDisk, and Penumbra led last week's large-cap gainers, with strong earnings and raised guidance fueling broad double-digit jumps.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

910.39M

Investing Cash Flow (TTM)

-499.01M

Financing Cash Flow (TTM)

-135.13M

Free Cash Flow (TTM)

745.84M

Capital Expenditure (TTM)

-164.54M

Net Change in Cash (TTM)

276.25M

Analyst Trends and Forecast

3

May

1

Jun

3

1

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$10.35B

PE Ratio (TTM)

20.63

PE Ratio (FWD)

15.13

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.51

PB Ratio (TTM)

2.27

Earnings Yield % (TTM)

4.85%

Earnings Yield % (FWD)

6.61%

EV / EBITDA (TTM)

10.85

Price / EBITDA (TTM)

11.58

Price / Free Cash Flow (TTM)

14.80

Book Value / Share

$35.52

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$507.75M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

$0

Key Statistics

Open

$80.43

Close

-

Volume / Avg.

897.86K / 1.60M

Day Range

$78.22 - $81.14

52 Wk Range

54.15 - 101.40

Market Cap

$10.54B

P/E Ratio

20.63

Dividend Yield

-

Exchange

NYSE

RSI

37

Short Interest

6.13%

Days to Cover

3.95

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which includ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Globus Medical (GMED) stock?

A

You can purchase shares of Globus Medical (NYSE:GMED) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Globus Medical (GMED) competitors?

A

Other companies in Globus Medical’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for Globus Medical (GMED) stock?

A

Globus Medical has a consensus price target of $96.74.

Q

What is the current price for Globus Medical (GMED)?

A

The stock price for Globus Medical (NYSE: GMED) is $78.53 last updated September 3, 2026 at 3:30 PM EDT.

Q

Does Globus Medical (GMED) pay a dividend?

A

There are no upcoming dividends for Globus Medical.

Q

When is Globus Medical (NYSE:GMED) reporting earnings?

A

Globus Medical does not have any upcoming earnings scheduled.

Q

Is Globus Medical (GMED) going to split?

A

There is no upcoming split for Globus Medical.

Q

What sector and industry does Globus Medical (GMED) operate in?

A

Globus Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.